10x Genomics Completes $55 Million Series C Financing Round
On March 17, 2016, 10x Genomics, a company focused on improving and broadening the application of next generation sequencing genomic information, announced that it has closed a $55 million Series C round of financing led by Fidelity Management & Research Company, with participation from Softbank, JS Capital Management, Venrock, Foresite Capital, and Paladin Capital. Wilson Sonsini Goodrich & Rosati represented 10x Genomics in the transaction.
According to a 10x Genomics press release, the new financing will accelerate the company's marketing and sales efforts in support of its genome sequencing products, while fueling innovative future product development.
For more information, please see 10x Genomics' press release.